Prevalence of HCV/HIV co-infection among haemophilia patients in Baghdad

Eastern Mediterranean Health Journal

Volumn 12, Issue 3-4, 2006, Pages 264-269

  Al Kubaisy, Wagar A ^a   Al Naib, K T ^a   Habib, M A ^a  

^a Al Nahrain University College of Medicine   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; COMPLEMENTARY DNA; VIRUS ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; ANTIBODY SCREENING; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; ENZYME IMMUNOASSAY; GENETIC VARIABILITY; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRAQ; POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEROPREVALENCE;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; CHILD; COMORBIDITY; DNA, VIRAL; DRUG CONTAMINATION; GENOTYPE; HEMOPHILIA A; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; IMMUNOENZYME TECHNIQUES; IRAQ; MASS SCREENING; MIDDLE AGED; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; URBAN HEALTH;

EID: 33749483776     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Dragoni F et al. Rapid liver failure related to chronic C hepatitis in an HIV seropositive haemophilic patient with severe immunodepression. Haematologica, 1996, 81(4):335-8.
2. Kasper CK, Kipnis SA. Hepatitis and clotting factor concentrates. Journal of the American Medical Association, 1972, 221(5):510.
3. Fletcher ML et al. Non A non B hepatitis after transfusion of factor VIII in infrequently treated patients. British medical Journal, 1983, 287(6407):1754-7.
4. Kernaff PA et al. High risk of non-A non-B hepatitis after first exposure to volunteer or commercial clotting factor concentrates: effect of prophylactic immune serum globulin. British journal of haematology, 1985, 60(3):469-79.
5. Preston FE et al. Heterogeneity of HCV genotypes in haemophilia: relationship with chronic liver disease. Blood, 1995, 85(5):1259-62.
6. Eyster ME et al. Increasing C virus RNA levels in hemophiliacs: relationship in human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study. Blood, 1994, 84(4):1020-3.
7. Telfer P et al. The progression of HCV-associated liver disease in a cohort of haemophilic patients. British journal of haematology, 1994, 87(3):555-61.
8. Telfer P et al. Alpha interferon for C virus infection in haemophilic patients. Haemophilia, 1995, 1:54-8.
9. Garson JA et al. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates. Lancet, 1990, 336(8722):1022-5.
10. Simmonds P et al. A proposed system for the nomenclature of hepatitis C viral genotype. Hepatology, 1994, 19(5):1321-4.
11. Ockenga J et al. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. Journal of hepatology, 1997, 27(1):18-24.
12. Makris M et al. Hepatitis C antibody and chronic liver disease in haemophilia. Lancet, 1990, 335(8698):1117-9.
13. Brettler DB et al. Prevalence of hepatitis C virus antibody in a cohort of haemophilia patients. Blood, 1990, 76(1):254-6.
14. Pistello M et al. Hepatitis C virus sero-prevalence in Italian haemophiliacs injected with virus inactivated concentrates: five year follow-up and correlation with antibodies to other viruses. Journal of medical virology, 1991, 33(1):43-6.
15. Yee TT et al. The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985. Gut, 2000, 47:845-51.
16. Hanley JP et al. Patterns of hepatitis G viraemia and liver disease in haemophiliacs previously exposed to non-virus inactivated coagulation factor concentrates. Thrombosis and haemostasis, 1998, 79(2):291-5.
17. Al-Kubaisy WA. Epidemiologic and genotypic distribution of hepatitis C in Iraqi pregnant women [thesis]. Baghdad, Saddam University (Al Nahrain University), 1998.
18. Saillour F et al. Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aquitaine. British medical journal, 1996, 313(7055):461-4.
19. Schreiber GB et al. The risk of transfusion-transmitted viral infections. New England journal of medicine, 1996, 334(26):1685-90.
20. Hepatitis C. Geneva, World Health Organization, 2000 (Fact sheet No. 164).
21. Tremolada F et al. Antibody to hepatitis C virus in post-transfusion hepatitis. Annals of internal medicine, 1991, 114(4):277-81.
22. Alter HJ et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. New England journal of medicine, 1989, 321(22):1494-500.
23. Sabin CA et al. The association between hepatitis C virus and human immunodeficiency virus disease progression in a cohort of haemophilic men. Journal of infectious diseases, 1997, 175(1):164-8.
24. Haydon GH et al. The impact of hepatitis C virus infection on HIV disease and progression in intravenous drug users. European journal of gastroenterology and hepatology, 1998, 10(6):485-9.
25. Daar ES et al. Hepatitis C virus is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs. Journal of infectious diseases, 2001, 183(4):589-95.
26. Fretz C et al. HCV infection in a rural population of the Central Africa Republic (CAR): evidence of three additional subtypes of genotype 4. Journal of medical virology, 1995, 47(4):435-7.
27. Devereux H et al. Hepatitis C genotypes in haemophilic patients treated with alpha-interferon. Journal of medical virology, 1995, 45(3):284-7.
28. Rapicetta M et al. Molecular heterogenicity and new subtypes of HCV genotype 4. Research in virology, 1998, 149(5):293-7.
29. Sherman K et al. HCV prevalence among patients infected with Human Immunodeficiency Virus: a cross sectional analysis of the US adults AIDS Clinical Trial Group. Clinical infectious diseases, 2002, 34(6):831-7.
30. Carten M et al. Comparative sensitivity of HCV antibody vs qualitative RNA in screening for HCV in HIV infected patients. Paper presented at the 9th conference on retroviruses and opportunistic infection, Seattle, 28 February 2002.
31. Dieterich DT, Purow JM, Rajapaksa R. Activity of combination therapy with interferon alfa-2b plus ribavirin in chronic hepatitis C patients co-infected with HIV. Seminars in liver disease, 1999, 19(suppl. 1):87-94.